Insiders Cytokinetics, Incorporated

Equities

CYTK

US23282W6057

Real-time Estimate Cboe BZX Other stock markets 02:05:08 2024-05-28 pm EDT			5-day change	1st Jan Change
47.27 ^USD	-2.13%		-21.38%	-43.37%

06:21pm	JMP Securities Adjusts Cytokinetics Price Target to $78 From $106, Maintains Market Outperform Rating	MT
May. 23	Raymond James Adjusts Price Target on Cytokinetics to $70 From $92, Maintains Outperform Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cytokinetics, Incorporated Announces Resignation of Sandford D. Smith as Board of Directors	May. 17	CI
Cytokinetics Insider Sold Shares Worth $1,012,265, According to a Recent SEC Filing	May. 07	MT
Cytokinetics Appoints Sung Lee as CFO	Apr. 26	MT
Cytokinetics, Incorporated Appoints Sung H. Lee as Executive Vice President, Effective as of May 8, 2024	Apr. 26	CI
Cytokinetics Insider Sold Shares Worth $2,422,918, According to a Recent SEC Filing	Apr. 09	MT
Cytokinetics Insider Sold Shares Worth $960,625, According to a Recent SEC Filing	Feb. 13	MT
Cytokinetics Insider Sold Shares Worth $2,585,497, According to a Recent SEC Filing	Feb. 06	MT
Cytokinetics Insider Sold Shares Worth $994,625, According to a Recent SEC Filing	Feb. 02	MT
Cytokinetics, Incorporated Announces Resignation of Ching W. Jaw as Chief Financial Officer, Effective February 23, 2024	Feb. 02	CI
Cytokinetics, Incorporated Announces Resignation of Ching W. Jaw, Senior Vice President, Effective February 23, 2024	Feb. 02	CI
Cytokinetics Insider Sold Shares Worth $425,700, According to a Recent SEC Filing	Jan. 12	MT
Cytokinetics Insider Sold Shares Worth $1,363,712, According to a Recent SEC Filing	Jan. 04	MT
Cytokinetics Insider Sold Shares Worth $1,063,500, According to a Recent SEC Filing	Jan. 02	MT
Cytokinetics Insider Sold Shares Worth $736,000, According to a Recent SEC Filing	Dec. 27	MT
Cytokinetics Insider Sold Shares Worth $461,875, According to a Recent SEC Filing	Dec. 19	MT
Cytokinetics Insider Sold Shares Worth $412,375, According to a Recent SEC Filing	Dec. 01	MT
Cytokinetics Insider Sold Shares Worth $432,125, According to a Recent SEC Filing	Nov. 15	MT
Cytokinetics Insider Sold Shares Worth $402,125, According to a Recent SEC Filing	23-10-30	MT
Cytokinetics Insider Sold Shares Worth $421,250, According to a Recent SEC Filing	23-10-16	MT
Cytokinetics Insider Sold Shares Worth $375,000, According to a Recent SEC Filing	23-10-06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Cytokinetics, Incorporated

Equities

CYTK

US23282W6057

Insiders

Filters